Compagnie Lombard Odier SCmA’s Zymeworks ZYME Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,000	Closed	-$102K	–	507
2024 Q4	$102K	Sell	7,000 -3,000	-30%	-$42K	﹤0.01%	294
2024 Q3	$126K	Hold	10,000	–	–	﹤0.01%	272
2024 Q2	$85.1K	Hold	10,000	–	–	﹤0.01%	298
2024 Q1	$105K	Hold	10,000	–	–	﹤0.01%	297
2023 Q4	$104K	Hold	10,000	–	–	﹤0.01%	347
2023 Q3	$63.4K	Hold	10,000	–	–	﹤0.01%	402
2023 Q2	$86.4K	Hold	10,000	–	–	﹤0.01%	365
2023 Q1	$90.4K	Hold	10,000	–	–	﹤0.01%	386
2022 Q4	$79K	Hold	10,000	–	–	﹤0.01%	422
2022 Q3	$61K	Hold	10,000	–	–	﹤0.01%	444
2022 Q2	$53K	Hold	10,000	–	–	﹤0.01%	431
2022 Q1	$66K	Buy	10,000 +7,000	+233%	+$62.4K	﹤0.01%	419
2021 Q4	$49K	Hold	3,000	–	–	﹤0.01%	510
2021 Q3	$87K	Buy	+3,000	New	+$99.7K	﹤0.01%	445

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ZYME Position: Q1 2025 in Review

Compagnie Lombard Odier SCmA sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 7,000 shares — an estimated $102K sold.

Compagnie Lombard Odier SCmA first reported a position in ZYME in Q3 2021 and held it in 14 quarters. The position peaked at $126K in Q3 2024. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

Compagnie Lombard Odier SCmA reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 7,000 Zymeworks shares in Q1 2025, an estimated $102K.
Compagnie Lombard Odier SCmA first reported a position in Zymeworks in Q3 2021 and held it in 14 quarters.
Compagnie Lombard Odier SCmA's Zymeworks position peaked at $126K in Q3 2024.
184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2025, filed 16 Apr 2025.